The stem cell-specific intermediate filament nestin missense variation p.A1199P is associated with pancreatic cancer
The stem cell-specific intermediate filament nestin missense variation p.A1199P is associated with pancreatic cancer
复制标题
DOI:
10.3892/ol.2019.10106
复制
发表时间:
2019-05-01
期刊:
影响因子:
2.9
通讯作者:
Arai, Tomio
中科院分区:
文献类型:
--
作者:
Matsuda, Yoko;Tanaka, Masashi;Arai, Tomio
The intermediate filament nestin is upregulated in stem/progenitor cells and cancers, and regulates cell proliferation, migration, invasion and stemness. The present study comparatively analyzed serial autopsies of Japanese patients (n=2,206; males, 1,225; females, 981; median, 80.7 years old; range, 33-104 years old) with malignant tumors of whole organs, with respect to the clinical information, and 5 single nucleotide polymorphisms of the nestin gene. p.A1199P associated with pancreatic cancer (odds ratio, 4.4; 95% confidence interval, 1.9-10.0, P=0.001) while it did not associate with malignant neoplasms in other organs. p.A1199P did not associate with precancerous lesions of the pancreas. Single nucleotide polymorphisms of nestin were not associated with sex, drinking, smoking, or body weight. In conclusion, the amino acid 1,199 of nestin is localized in the tail structure of the filament and polymerizes with other intermediate filament proteins. The present results suggest that missense variations of nestin affect pancreatic carcinogenesis in Japanese patients.